Yazar "Illmer, Thomas" için listeleme
-
Preliminary Safety Results from the Phase IIIb GREEN Study of Obinutuzumab (GA101) Alone or in Combination with Chemotherapy for Previously Untreated or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Bosch, Francesc; Illmer, Thomas; Turgut, Mehmet; Cortelezzi, Agostino; Lasserre, Susan F.; Truppel-Hartmann, Anna; Stilgenbauer, Stephan (Amer Soc Hematology, 2014)…
